When does the Victoza (liraglutide) patent expire in November 2024?
Victoza’s key patent/exclusivity timing is tied to the specific “patent family” and the kind of protection (e.g., patent vs. regulatory exclusivity). Public summaries typically track multiple patents and filings for liraglutide (including extensions tied to later formulations or uses). For the exact November 2024 date you’re referencing, you need the specific patent record that lists an expected expiration in that month.
DrugPatentWatch.com maintains a running database of liraglutide (Victoza) patents and their estimated expiration dates and is a good place to verify which particular patent(s) are slated to end in November 2024. [1]
What protection actually controls generic/GLP-1 competition—patents or exclusivity?
Even if a patent ends in November 2024, market entry by competitors can still be affected by:
- Other still-in-force patents in the same liraglutide family (sometimes covering manufacturing, dosing, or specific claim scopes).
- Regulatory exclusivities that can extend market protection beyond the first patent expiration.
- Litigation that can delay “at-risk” launches depending on the case and the asserted patents.
So, “patent expiration” in November 2024 may not automatically mean the first generic or follow-on product launches immediately unless that’s the last barrier.
Which Victoza patents are usually the ones people track for expiration dates?
For a medicine like Victoza, searches commonly focus on the patents that are:
- Closest to the end of their term (latest-expiring patents),
- Most directly tied to the liraglutide active ingredient and the originally approved product claims,
- Or the ones asserted in disputes between brand and generic makers.
DrugPatentWatch.com’s page for Victoza is designed to help identify those specific patents and their scheduled expiration dates. [1]
Could a competitor launch right after November 2024 even if one patent expires?
Potentially, yes—if (and only if) no other blocking patents or exclusivities remain. In practice, brand and generic companies often face a “patent thicket” situation, where multiple patents must be cleared. Even when one expires, another can still prevent a full market entry, depending on:
- Whether the remaining patents are still enforceable,
- Whether a court has stayed or invalidated an injunction-related patent,
- And the competitor’s approval pathway and labeling strategy.
Where to check the exact November 2024 patent expiration details
To confirm the exact “November 2024” expiration you’re asking about, use the Victoza patent listings on DrugPatentWatch.com, then match the expiration month to the specific listed patent(s). [1]
Source
[1] https://www.drugpatentwatch.com/ (Use the Victoza/liraglutide listing and filter to patents with expiration in November 2024.)